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ORIGINAL ARTICLE 
A comparison of intraoperative cell salvage use with 
cardiotomy suction in cardiothoracic surgery  
 Edward Muscat, Timothy Miggiani,  David Sladden, Alexander Manche’
INTRODUCTION  
Intraoperative cell salvage has been shown to be a safe and effective 
means of autologous blood recirculation in elective surgery. Most 
cardiac units now employ cell salvage for complex procedures but 
few use it routinely in all cardiac procedures requiring 
cardiopulmonary bypass.  
AIM  
To demonstrate if there was any haematological benefit of 
autologous transfusion using intra- operative cell salvage over single 
use of cardiotomy suction in patients undergoing cardiac surgery.  
METHODS  
All patients who had operations performed by the cardiac surgical 
team over a twenty-month period formed part of this study including 
valve replacements and coronary artery bypass grafting. The patients 
were divided into two groups; the cell saver group and the control 
group. The haematological variations of these patients’ blood results 
were analysed preoperatively, immediately post-operatively and 24 
hours post-operatively.  
RESULTS  
451 patients were operated on during this period. 230 patients in the 
control group and 221 patients in the cell saver group. Intra-
operative cell salvage demonstrated better immediate post- 
operative haemoglobin levels (10.31 g/dL) compared to the non-cell 
saver group (9.99 g/dL). The p-value was 0.003 after comparison 
between pre-operative haemoglobin and post-operative 
haemoglobin in the cell saver group.  
CONCLUSION  
Intra-operative cell salvage demonstrated a minimal increment in 
haemoglobin levels in the immediate post-operative period when 
compared with cardiotomy suction alone. Even though the 
improvement in haemoglobin is only significant until 24 hours post-
operation, overall this showed an improved haematological 
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INTRODUCTION  
Major surgery, especially cardiac surgery, is a 
challenge to the hematopoietic system. It is 
well known that patients with cardiac disease, 
namely ischaemic heart disease and 
hypertrophic cardiomyopathy, cannot tolerate 
a decrement in haemoglobin and haematocrit 
levels. Cardiac surgery carries a high burden in 
terms of blood loss and transfusion 
requirement, and hence transfusion related 
injuries. The National Blood Service in the UK 
advocates that 10% of its stored blood 
supplies are used in cardiac surgery alone.1 The 
continued use of allogeneic erythrocyte 
transfusions is associated with adverse effects 
such as myocardial ischaemia, acute lung injury 
and an overall raised mortality index.2 
According to various authors, a haemoglobin 
of 10 g/dl and a haematocrit of 30% indicated 
desirable goals in anaemic patients 
undergoing cardiac surgery.3 Blood is a limited 
yet costly resource and it should be utilised as 
sparingly as possible. The autologous options 
for surgical blood conservation circumvent the 
transfusion of allogeneic blood. Options 
include preoperative autologous blood 
donation, intra-operative haemoconcentration 
and blood salvage.  
The cardiotomy suction apparatus was 
introduced first in the 1960s as an extension of 
the intracardiac vent to allow blood lost during 
the operation to be returned via the 
cardiopulmonary bypass (CPB) circuit. The aim 
was to reduce blood loss and hence the need 
for allogeneic blood transfusions with its 
known risk of increased morbidity however 
this is not always the case as evidence suggests 
that recirculated cardiotomy suctioned blood 
neither reduces blood loss nor transfusion 
requirements.4 Intra-operative cell salvage 
(ICS) during cardiac surgery is widely accepted; 
a meta‐analysis of 31 trials showed that 
routine use reduced the transfusion of red 
cells by 40%.5 
It works by collection, washing, and re-
infusion. Collection involves the use of a 
double-lumen suction device. One lumen 
drains blood from the operative field and the 
other lumen adds a dose of heparinized saline 
to the drained blood. The anticoagulated 
blood is then passed through a filter, which is 
then collected in a reservoir. Centrifugation 
splits the blood into separate components. 
The red blood cells (RBCs) are then isolated 
and washed which are then filtered across a 
semi-permeable membrane. The free 
haemoglobin, plasma, platelets, white blood 
cells, and heparin become removed at this 
stage. The same RBCs are infused in normal 
saline transforming the haematocrit to 50–
80%. Blood can then be transfused 
immediately or within a six-hour time frame.6 
ICS is purported to feature benefits such as a 
decreased need for allogeneic blood 
transfusions and increased cost-effectiveness. 
It has been argued that ICS has financial 
benefits over erythrocyte transfusion in the 
setting of homologous blood is becoming 
more expensive. Furthermore, leucodepletion 
of blood in the post Creutzfeldt-Jakob disease 
era has quadrupled the cost of allogeneic 
blood transfusion.7 It also avoids the potential 
side effects such as the transmission of viral 
illnesses, transfusion reactions and 
immunosuppressive infections associated with 
blood transfusions.8 In addition, it can be 
associated with a lower risk of cerebral lipid 
embolism.9 
The principal drawback of ICS in the literature 
is dilutional coagulopathy as blood that is 
salvaged lacks clotting factors. It has also been 
argued that since the introduction of drugs, 
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lower priming volumes and intravascular 
shunts blood loss has been minimised to the 
extent that ICS is no longer warranted.1 At the 
time of writing this study there have been 
many publications highlighting the benefits of 
cell saver over cardiotomy suction but few 
recommend its routine use in cardiac surgery. 
Its use needs to be justified by analysing post- 
operative improvement in haemoglobin and 
haematocrit levels.  
Therefore, the aim of our clinical study was to 
evaluate the effects of autologous cell saver 
blood transfusion on blood loss and changes in 
haemoglobin and haematocrit concentrations 
in the cardiac operations done in between over 
a one year period in Mater Dei Hospital in 
Malta. The literature has shown that the values 
of blood markers (number, size, function) 
produce changes during the early phase of 
cardiac surgery, steady recovery during the 
postoperative period achieving preoperative 
values 2-6 months after surgery.10  
MATERIALS AND METHODS 
This study included all patients who had 
operations performed by the cardiac surgical 
team over a twenty-month period. Inclusion 
criteria consisted of all major cardiac surgical 
operations within this period including valve 
replacements (aortic and/or mitral). coronary 
artery bypass grafting (emergency or elective), 
aortic graft, cardiac tamponade and aortic root 
replacement. All patients underwent a general 
anaesthetic and standard practice of 
cardiopulmonary bypass. 
The selected patients were organised into two 
groups namely the control (non-cell saver) and 
the cell saver groups. Data collection included 
patient demographics and hospital numbers, 
which were processed by the local hospital 
clinical manager software, iSoft, in order to 
retrieve their individual haematology results. 
The main focus of this study was primarily 
interpretation of trends of Haemoglobin (Hb) 
and Haematocrit (Hct). In order to accurately 
measure the trend of haematological variation 
throughout the patients’ hospital stay blood 
results preoperatively, immediately post-
operatively and 24 hours post-operatively 
(delayed) were obtained for analysis. All 
statistical analysis was performed using the 
SAS statistical software programme. We 
considered results to be significant at p value < 
0.05.  
The cell saver system was implemented in the 
year of 2015 in Mater Dei Hospital, Malta. 
Therefore, acquisition of control group 
patients was historical and occurred prior to 
the cell saver group being between January 
2014 to September 2014. An equivalent 
number of control cases were recorded before 
the introduction of the cell saver machine and 
this included matching criteria. These weren't 
case matched on an individual basis however 
the average group demographics were 
consistent with similar risk factors and co-
morbidities. Data for the cell saver group was 
collected prospectively as the operations were 
performed over time. The two cohorts were 
matched overall by a separate researcher prior 
to data collection of blood levels. All 
operations were performed by the same three 
cardiothoracic surgeons using relatively similar 
surgical methods and bypass times.  
RESULTS  
The total number of patients were 451 with a 
mean age of 64.75 years. 230 patients were in 
the control group and 221 patients in the cell 
saver group. The total number of operations is 
shown in table format in Table 1. The overall 
pre-operative haemoglobin mean was 
13.28g/dL in the cell saver group and 
13.47g/dL in the control group. The overall 
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mean preoperative haematocrit was 38.79% in 
the cell saver group and 39.15% in the control 
group. In both groups the average number of 
units of whole blood transfused to the 
patients were the same. 
 
Table 1 Table including the categories of cases in this study 
 Control Cell saver 
Total patients 230 221 
Number of total AVR cases 54 60 
Number of total MVR cases 17 27 
CABG cases 169 139 
Combined AVR + MVR cases 1 2 
Combined CABG +VR 13 10 
 
Figure 1 Bar graph showing the comparison of haemoglobin values between cell saver and non-













An important result from both group findings 
was mainly the p-value of 0.003 after 
comparison between pre-operative 
haemoglobin and post-operative haemoglobin 
in the cell saver group which is statistically 
significant for this study being that confidence 
intervals were all 95% (Figure 1). The same 
cannot be said for delayed post-operative 
haemoglobin which did not show any 
statistical significance when comparing pre-
operative haemoglobin (p=0.143). Therefore, 
an increment was found amongst the cell saver 
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patients compared to control group patients in 
terms of immediate post-operative 
haemoglobin levels considering the pre-
operative Hb even was lower for the cell saver 
grouped patients. Minor haematocrit 
difference was observed between both groups 
both immediately post-operation (p=0.643) 
and delayed post- operation (p=0.766).  
DISCUSSION  
Intraoperative autologous red cell salvage 
during cardiac surgery is an attractive 
alternative to the continued single use of 
cardiotomy suction. From our study we have 
observed that ICS was associated with better 
post-operative haemoglobin results compared 
to the control group in the immediate post-
operative period. Similar results were also 
mentioned by Marcoux et al in his study where 
post-operative haemoglobin concentrations, 
in cardiac surgical patients, were significantly 
higher in the ICS group consequently spending 
significantly less time in the Intensive Care 
Unit (ICU).11 In terms of delayed post-operative 
haemoglobin results both groups had similar 
results with the cell saver group having 
haemoglobin levels that were, again, slightly 
higher.  
When first introduced in the 1980s, some 
authors had opposing views against the use of 
ICS, because it would neither decrease the 
costs nor the requirement of autologous 
blood. Since then, several studies have 
emerged highlighting the advantages in the 
use of ICS being that it increases haemoglobin 
concentration and utilizes less use of allogenic 
blood transfusion in the post-operative 
period.12 Several other studies have shown 
advantages in the use of the cell salver. 
Almeida et Leitao also mentioned that use of a 
cell saver mechanism results in shorter 
hospitalization time in ICU (one day less) and a 
reduction of the use of red blood cell units 
during inpatient stay for cardiac surgical 
patients.  
Currently, misconceptions regarding the use of 
cell saver systems portray them as expensive, 
ineffective, and inappropriate for use in 
certain clinical situations. Several authors have 
demonstrated that the lack of use of red blood 
cells in the postoperative period decreases not 
only the morbidity but also intra and 
postoperative mortality. In a recent study, 
Côté et. al. retrospectively analysed outcomes 
of ICS in cardiac surgery revealing ICS group 
were less likely than the control group to be 
exposed to packed red blood cells, coagulation 
products or any blood products in the peri-
operative period.13 Since whole blood 
transfusion is used after cardiac surgery as a 
means to enhance cardiac output it was not 
analysed as a variable for cell saver 
performance in our study. Both groups had 
cardiotomy suction available providing an 
added benefit. In our study we had not noticed 
any significant difference in the number of 
units of blood products between both groups 
but as this is a pilot study of cardiac operations 
the patients received similar transfusion units 
post operatively and perhaps the team will 
become more confident in the ability of the 
cell saver system over the years. However, 
despite this postoperative hemoglobin levels 
increased in the cell saver group in the 
immediate setting. Few ICS studies stated as 
to whether or not remaining cardiopulmonary 
bypass contents were processed through the 
cell saver via cardiotomy suction. Those of 
which that did found a significant decrease in 
red blood cell transfusion and a decrease in 
postoperative chest tube drainage.14 
Interestingly, a randomised controlled trial 
(RCT) by Westerberg et al. comparing re-
transfusion of ICS and cardiotomy suctioned 
30
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blood effects in cardiac surgery showed 
cardiotomy suctioned blood being quite 
vasoactive decreasing the mean arterial 
pressure (MAP). The vasodilation was 
proportional to the release of inflammatory 
cytokines from cardiotomy suctioned blood 
and this is significantly reduced by using it 
alongside ICS.15  
Cardiopulmonary suction alone involves a 
highly turbulent flow of the suction which 
causes shear stresses at the air-fluid interface 
resulting in the stimulation of humoral 
cascades as part of the systemic inflammatory 
response. The shearing stress caused by a 
cardiotomy suction results in an increased 
amount of free haemoglobin due to 
mechanical haemolysis.7 Perhaps this is as to 
why there is a slight difference between the 
cell saver and control group blood results. It is 
well documented that not only does the single 
use of the cardiotomy suction in 
cardiopulmonary bypass (CPB) surgery is 
associated with a systemic inflammatory 
response but also a resulting coagulopathy as 
it exacerbates the microembolic load. High 
quantities of free haemoglobin can cause 
platelet disfunction and damage to renal 
tubular cells. Processing cardiotomy suctioned 
blood with a cell saver device is important 
factor to effectively reduce these 
inflammatory responses, yet this in itself might 
also have potential harmful effects for the 
patient16. In terms of safety with cell saver we 
know that heparin coated CPB circuit with the 
uncoated cardiotomy reservoir may be less 
biocompatible than the identical CPB set used 
together with cell saver mechanism. Borowiec 
et. al mentioned that cardiotomy suction 
produces a marked reduced ability to produce 
oxygen free radicals by the whole blood at 45 
minutes of CPB.17 Fat microembolic load is 
decreased by the cell saver by as much as 
85%.18 In a prospective randomised trial 
analysing fat percentage in recirculated blood 
in cardiac surgery the percentage reduction in 
fat weight achieved by cell saver and 
cardiotomy suction alone was 87% and 45% 
respectively.19  
In a RCT by Lau et al. recirculation of blood in 
the operative field significantly decreased the 
number of packed cells, platelets, and total 
blood products received in the test group 
when compared with the control group.20 200 
patients were randomised prospectively 
undergoing first time CABG to control or cell 
salvage (washed). The cell salvage group was 
significantly less likely to receive a 
homologous blood transfusion and they 
received significantly fewer units of blood or 
platelets than controls. Larger systematic 
reviews have been completed to address this 
clinical question.21 The Cochrane systematic 
review of Carless et al. did not differentiate 
between studies with washed and unwashed 
blood, but overall a similar result suggesting 
benefit of this technology.22  
Fat particles have been linked with neurologic 
disfunction associated with CPB which have 
been due to the presence of small capillary and 
arteriolar dilatations (SCADs) shown in the 
brain in post- mortem studies. Unprocessed 
cardiotomy blood has also resulted in the 
production of thrombin during cardiac surgery 
including markers of inflammation such as 
tumor necrosis factor, interleukin-6 (IL-6), 
complement and neuron-specific enolase.23 
Even though the use of cardiotomy suctioned 
blood poses a microvascular risk, Rubens et.al 
stated that there is no clinical evidence of any 
neurologic benefit with this approach in terms 
of postoperative cognitive function.24 This 
decrease in blood product utilization 
translated into a significant cost savings per 
patient in the available literature. We have not 
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analysed cost in this study as the cell saver 
device was initially a donation to the local 
department but it would be an interesting 
feature to do so in the future. In the same RCT 
Rubens et.al also stated there was less 
postoperative bleeding and less use of blood 
transfusions amongst the cell saver group in 
cardiac surgery.24 Our results are fairly 
consistent with other studies demonstrating 
that ICS results in increased post-operative 
haemoglobin rates, especially in cardiac 
surgical patients. Cardiac surgery patients are 
most at risk of myocardial ischaemia when 
haemoglobin levels fall and as a consequence 
are also at most risk of transfusion related 
complications especially acute lung injury.  
It has been suggested that cardiotomy suction 
alone produces an unbalanced ratio of pro and 
anti-inflammatory cytokines. A RCT by Gabel 
et. al discovered that cell savage in 
combination with cardiotomy suction 
decreased the concentrations for such 
cytokines improving the postoperative 
balance.25 Damgaard et al. suggested that ICS 
decreases circulatory levels of pro-
inflammatory markers IL-6 and IL-8 and 
increased immediate Hb levels at 6 hours post 
CPB26. Engels et al supports this with his RCT 
of inflammatory cytokines in cardiac surgery 
which indicated lower levels of Clara cell 16 kD 
proteins (CC16) resulting in less lung injury in 
the ICS group compared to controls. The ICS 
group had shorter ventilation times.27  
Cell salvage is not however entirely without its 
problems. The air-fluid interface remains, 
however, the presence of heparin at the tip of 
the suction reduces the activation of the 
clotting and inflammatory cascades. It is 
almost predicable that if very large volumes of 
blood are processed through a cell saver it will 
deplete that volume of blood of platelets and 
clotting factors, careful monitoring and 
replacement of these may be necessary6. Shen 
et. al performed a RCT on high-risk cardiac 
surgical patients and discovered that ICS could 
impair blood coagulation and found excessive 
bleeding post operatively in this group28. Even 
though complications associated with the use 
of ICS are rare, studies have shown no overt 
increase in the rate of complications in 
patients who receive ICS.29  
CONCLUSION 
This study recommends the use of the cell 
saver system in cardiac surgery to reduce the 
probability of severe postoperative anaemia. 
As also stated by the ASA guidelines, we 
support the recommendation to keep its 
availability for immediate use 24 hours a day in 
any center undertaking surgery where blood 
loss is a recognised potential complication.30 
Although the use of ICS did not decrease the 
rate of red blood cell transfusion there were 
higher postoperative hemoglobin levels in 
immediate post-operative settings compared 
with cardiotomy suction alone. The literature 
seems to support use of combined ICS with 
cardiotomy suction as they effectively 
decrease inflammatory cytokines which can 
cause complications. However, excess cell 
saver use alone may decrease circulating 
clotting factors in high risk bleeding cardiac 
surgery.31 Therefore, we do not recommend 
cell saver use without cardiotomy suction in 
cardiac surgery. It would be worth comparing 
both groups in terms of post-operative 
bleeding in future cohorts. 
SUMMARY BOX  
 What is already known about this subject: 
• Benefits of ICS include less time in ICU, 
shorter ventilation times and a shorter 
hospital   stay in surgical patients.  
32
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• ICS causes a depletion of clotting factor 
and platelets due to hemofiltation of 
recirculated blood.  
• Cardiotomy suction alone causes 
mechanical hemolysis increasing 
transfusion requirements whilst 
maintaining clotting factors.  
What are the new findings:  
• Immediate post-operative haemoglobin 
levels are increased with the use of ICS in 
cardiac surgery compared with cardiotomy 
suction alone.  
• No significant changes in hemoglobin 
found in the late post-operative period 
using the cell  
saver. No significant changes in hematocrit 
using a cell saver mechanism.  
• An addition to the literature to support a 
combination of cell saver mechanism with 
cardiotomy suction in cardiac surgery.
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